What is Travere Therapeutics, Inc.'s convertible debt - current?

Travere Therapeutics, Inc. (TVTX) reported convertible debt - current of $312.08M in Q1 2026.

Travere Therapeutics, Inc. TVTX Convertible Debt - Current

Convertible Debt - Current at other companies

BillionToOne, Inc. BLLN

$0-100%

Ondas, Inc. ONDS

$10M+400%

ImaxIMAX

$244.13M+6.1%

WisdomTreeWT

$74.91M—

KEE

Keel Infrastructure Corp. Common StockKEEL

$588M—

Flagstar Bank FLG

$1M0.0%

Other financials

Income statement

See full

Revenue$127.2M+55.6%

Gross profit$125.2M+62.5%

Operating income-$36.9M+13.5%

Net income-$37.1M+10.0%

EPS (diluted)-$0.40+14.9%

Balance sheet

See full

Cash & equivalents$78.4M+26.6%

Total debt$15.6M-82.6%

Total equity$98.7M+201%

Total assets$555.2M+1.2%

Cash flow

See full

Operating cash flow-$40.4M+4.3%

CapEx$140.0K—

Free cash flow-$42.5M+28.1%

Valuation

See full

Market cap$5.2B+72.3%

Profitability

See full

Gross margin98.6%+2.6pp

Operating margin-10.6%-5.0pp

Net margin-20.3%-9.5pp

FCF margin-133.9%-34.4pp

Returns & leverage

See full

Return on equity-706%-1,302pp

Debt / equity0.2×-2.6×

Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebt.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s convertible debt - current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s convertible debt - current?: Travere Therapeutics, Inc. (TVTX) reported convertible debt - current of $312.08M in Q1 2026.